Baxter International Inc. (BAX)
$17.31
$-0.58
(-3.24%)
As on 13-May-2026 16:13EDT
Market cap
$9,054 Mln
Revenue (TTM)
$11,320 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
2 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-1,083 Mln
-
ROE
-0.2 %
-
ROCE
-5.2 %
-
Industry P/E
44.07
-
EV/EBITDA
22.6
-
Debt to Equity
1.4
-
Book Value
$--
-
EPS
$-2.1
-
Face value
--
-
Shares outstanding
516,469,008
10 Years Aggregate
CFO
$19,550.00 Mln
EBITDA
$20,409.00 Mln
Net Profit
$14,393.00 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Baxter International (BAX)
| -9.4 | 0.9 | -7.5 | -44.0 | -25.9 | -26.9 | -9.2 |
|
BSE Sensex*
| -11.0 | -1.9 | -8.7 | -7.1 | 6.7 | 9.1 | 11.5 |
|
S&P Midcap 400
| 9.2 | 3.7 | 3.5 | 19.8 | 14.5 | 6.8 | 9.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Baxter International (BAX)
| -34.5 | -24.4 | -24.2 | -40.6 | 8.5 | -3.0 | 28.4 |
|
S&P Midcap 400
| 5.9 | 12.1 | 14.4 | -14.5 | 23.2 | 11.8 | 24.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Baxter International (BAX)
|
17.3 | 9,053.7 | 11,320.0 | -1,098.0 | -2.0 | -16.5 | -- | 1.5 |
| 83.8 | 143,804.1 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 23.1 | 2.8 | |
| 243.5 | 6,524.2 | 2,589.9 | 168.8 | 21.4 | 2.5 | 40.6 | 1.0 | |
| 75.6 | 10,408.9 | 3,100.6 | 586.7 | 14.2 | 12.9 | 17.9 | 2.2 | |
| 69.5 | 7,859.1 | 13,384.0 | 395.0 | 5.2 | 11.2 | 20.8 | 2.5 | |
| 148.8 | 10,678.5 | 2,900.9 | 302.8 | 15.9 | 22.5 | 35.9 | 8.2 | |
| 432.3 | 148,769.7 | 10,582.1 | 2,979.1 | 22.4 | 17.2 | 51 | 9.1 | |
| 25.6 | 25,447.4 | 17,706.2 | 972.5 | 8.7 | 8.8 | 22.7 | 1.9 | |
| 130.0 | 5,742.7 | 2,811.2 | -1,008.8 | -7.9 | -29.2 | 2162 | 1.9 | |
| 446.0 | 168,195.9 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 24.9 | 3.3 |
Shareholding Pattern
View DetailsAbout Baxter International (BAX)
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.... It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois. Address: One Baxter Parkway, Deerfield, IL, United States, 60015 Read more
-
Chairman of the Board, President & CEO
Mr. Jose E. Almeida
-
Executive VP, CFO & Interim Chief Accounting Officer
Mr. Joel T. Grade
-
Headquarters
Deerfield, IL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Baxter International (BAX)
What is the current share price of Baxter International Inc (BAX) Today?
The share price of Baxter International Inc (BAX) is $17.31 (NYSE) as of 13-May-2026 16:13 EDT. Baxter International Inc (BAX) has given a return of -25.86% in the last 3 years.
What is the current PB & PE ratio of Baxter International Inc (BAX)?
Since, TTM earnings of Baxter International Inc (BAX) is negative, P/E ratio is not available.
The P/B ratio of Baxter International Inc (BAX) is 1.54 times as on 12-May-2026, a 47 discount to its peers’ median range of 2.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-10.26
|
1.60
|
|
2024
|
-22.91
|
2.14
|
|
2023
|
7.38
|
2.33
|
|
2022
|
-10.62
|
4.43
|
|
2021
|
33.89
|
4.79
|
What is the 52 Week High and Low of Baxter International Inc (BAX)?
The 52-week high and low of Baxter International Inc (BAX) are Rs 32.04 and Rs 15.73 as of 14-May-2026.
What is the market cap of Baxter International Inc (BAX)?
Baxter International Inc (BAX) has a market capitalisation of $ 9,054 Mln as on 12-May-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Baxter International Inc (BAX)?
Before investing in Baxter International Inc (BAX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.